[1] Tay SY,Ampil ER,Chen CP,et al. The relationship between homocysteine,cognition and stroke subtypes in acute stroke[J]. J Neurol Sci,2006,250(1-2):58-61. [2] Kim JY,Hyun YJ,Jang Y,et al.Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress:a case-control study[J].Am J Clin Nutr,2008,88(3):630-637. [3] Brilakis ES,Khera A,Saeed B,et al.Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis:finding from the Dallas Heart Study[J].Clin Chem,2008,54(12):1975-1981. [4] Mannheim D,Herrmann J,Versari D,et al. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques[J]. Stroke,2008,39(5):1448-1455. [5] 各类脑血管病诊断要点[J].中华神经科杂志,1996,42(6):60-61. [6] Stewart RA,White HD. The role of lipoprotein-associated phospholipase a2 as a marker and potential therapeutic target in atherosclerosis[J]. Curr Atheroscler Rep,2011,13(2):132-137. [7] Colley KJ,Wolfert RL,Cobble ME. Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk[J]. EPMA J,2011,2(1):27-38. [8] Ninio E,Tregouet D,Carrier JL,et al. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease[J]. Hum Mol Genet,2004,13(13):1341-1351. [9] Serruys PW,García-García HM,Buszman P,et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque[J]. Circulation,2008,118(11):1172-1182. [10] Jenny NS,Solomon C,Cushman M,et al. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults:results from the Cardiovascular Health Study[J]. Atherosclerosis,2010,209(2):528-532. [11] Mannheim D,Herrmann J,Versari D,et al. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques[J]. Stroke,2008,39(5):1448-1455. [12] 邬建民,张 力.脂蛋白相关磷脂酶A2在冠心病患者严重程度评估中的应用[J].检验医学,2011,26(2):85-87. [13] Macphee CH,Nelson J,Zalewski A. Role of lipo-protein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target[J]. Curr Opin Pharmacol,2006,6(2):154-161. |